Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials.
Kimball AB, Jemec GBE, Alavi A, Reguiai Z, Gottlieb AB, Bechara FG, Paul C, Giamarellos Bourboulis EJ, Villani AP, Schwinn A, Ruëff F, Pillay Ramaya L, Reich A, Lobo I, Sinclair R, Passeron T, Martorell A, Mendes-Bastos P, Kokolakis G, Becherel PA, Wozniak MB, Martinez AL, Wei X, Uhlmann L, Passera A, Keefe D, Martin R, Field C, Chen L, Vandemeulebroecke M, Ravichandran S, Muscianisi E. Kimball AB, et al. Among authors: lobo i. Lancet. 2023 Mar 4;401(10378):747-761. doi: 10.1016/S0140-6736(23)00022-3. Epub 2023 Feb 3. Lancet. 2023. PMID: 36746171 Clinical Trial.
The inter-rater reliability of IHS4 corroborates its aptitude as primary outcome measurement instrument for large clinical studies in hidradenitis suppurativa.
Zouboulis CC, Hrvatin Stancic B, Abaitancei A, Guimarães MJ, Lobo IL, Massa AF, Nikolakis G, Nogueira MO, Özdemir AO, Pirogova A, Prens EP, Szepietowski JC, Tusheva I, Tzellos T, Zouboulis VA. Zouboulis CC, et al. Among authors: lobo il. J Eur Acad Dermatol Venereol. 2024 Feb;38(2):e185-e187. doi: 10.1111/jdv.19525. Epub 2023 Oct 4. J Eur Acad Dermatol Venereol. 2024. PMID: 37728531 No abstract available.
Incidence of drug-related adverse events related to the use of high-alert drugs: A systematic review of randomized controlled trials.
Menezes MS, Doria GAA, Valença-Feitosa F, Pereira SN, Silvestre CC, de Oliveira Filho AD, Lobo IMF, Quintans-Júnior LJ. Menezes MS, et al. Among authors: lobo imf. Explor Res Clin Soc Pharm. 2024 Apr 8;14:100435. doi: 10.1016/j.rcsop.2024.100435. eCollection 2024 Jun. Explor Res Clin Soc Pharm. 2024. PMID: 38646469 Free PMC article. Review.
127 results